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Supplemental Figure 1.  
(A): Il-6 expression detected by microarray analysis in the indicated genotype of 
prostate epithelial cells. Columns: relative frequency plus S.D. (N = 3 in the left panel 
and N = 4 in the right panel). **P < 0.01 and ***P < 0.001 (Student′s t-test). (B): Lox 
expression detected by microarray analysis in the indicated genotype of prostate 
epithelial cells. Columns: relative frequency plus S.D. (N = 3 in the left panel and N = 4 
in the right panel). ***P < 0.001 (Student′s t-test). (C): Il-6 expression detected by 
RT-qPCR in the indicated genotype of prostate epithelial cells transduced with the 
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indicate shRNA. Columns: relative frequency plus S.D. (N = 3). ***P < 0.001 
(Student′s t-test).  
 
Supplemental Figure 2.  
A GSEA result for genes upregulated in p53-/-; Rbf/f cells after infection with Ad-Cre as 
compared to Ad-LacZ against one of gene sets that features genes expressed in 
embryonic stem (ES) cells (Wong et al., 2008). 
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Supplemental Figure 3. 
RT-qPCR of Il-6 in the indicated genotype of primary prostate cells treated with 20μM 
IKK-2 Inhibitor IV for 4 hr (A), 20 μM HLM006474 for 24 hr (B) or 10 μM LY294002 
for 4 hr (C). Columns: relative frequency plus S.D. (N = 3). (D) RT-qPCR of lox in the 
indicated genotype of primary prostate cells treated with 20 μM HLM006474 for 24 hr. 
Dimethyl sulfoxide (DMSO): a vehicle. Columns: relative frequency plus S.D. (N = 3). 
*P < 0.05 and ***P < 0.001 (one-way ANOVA followed by post-hoc Tukey's test). 
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Supplemental Figure 4. 
(A): Relative cell growth of the indicated genotype of prostate epithelial cells treated 
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with 20 ng/ml rIl-6 under monolayer culture condition for 48 hrs. Columns: relative 
frequency plus S.D. (N = 3). One-way ANOVA followed by post-hoc Tukey's test was 
used. The same analyses for cells transduced with Il-6 shRNA (B), treated with 0.4 μM 
anti-Il-6R antibody for 48 hrs (C), and transduced with Lox shRNA and observed for 96 
hrs (N = 1) (D).  
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